Mesothelioma Applied Research Foundation – “MARF” – Monoclonal antibody-drug-conjugate to target oncogenic ERK5 in mesothelioma
Project data Funding Entity: Mesothelioma Applied Research Foundation (MARF) Call: 2022-2023 Research Grant Cycle Coordinator: Università di Siena (Italy) UNISI Principal Investigator: Prof. Emanuele Giurisato Department: Department … Read More

